# A Phase II Study of Radiation Therapy to Treat Refractory Breast Cancer

> **NCT07672743** · NA · NOT_YET_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 29 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Radical dose radiotherapy

## Key facts

- **NCT ID:** NCT07672743
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672743, "A Phase II Study of Radiation Therapy to Treat Refractory Breast Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07672743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*